Cited by 87Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsLiver Disease and Transplantation

Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant

Open access
Vleggaar, F P, van Buuren, H R, Zondervan, P E, ten Kate, F J W, Hop, W C J, the Dutch Multicentre PBC study group·2001·Gut

Abstract

The clinical and pathological findings of four females with primary biliary cirrhosis (PBC) with an unusual and hitherto not well recognised course are reported. Patients suffered severe pruritus and weight loss with progressive icteric cholestasis which did not respond to such treatments as ursodeoxycholic acid and immunosuppressives. In all cases liver histology revealed marked bile duct loss without however significant fibrosis or cirrhosis. Further diagnostic studies and repeat biopsies confirmed the absence of liver cirrhosis as well as other potential causes of hyperbilirubinaemia. Comparison of the fibrosis-ductopenia relationship for our cases with that for a group of 101 non-cirrhotic PBC patients indicated that in the former the severity of bile duct loss relative to the amount of fibrosis was significantly higher. The proportion of portal triads containing an interlobular bile duct was 3%, 4%, 6%, and 10% compared with 45% (median; range 8.3–100%) for controls (p<0.001). Three patients received a liver transplant 6–7 years after the first manifestation of PBC because of progressive cholestasis, refractory pruritus, and weight loss, while the fourth patient is considering this option. In one case cirrhosis had developed at the time of transplantation while the others still had non-cirrhotic disease. These cases suggest that cholestatic jaundice in non-cirrhotic PBC may be secondary to extensive “premature” or accelerated intrahepatic bile duct loss. Although the extent of fibrosis may be limited initially, progression to cirrhosis appears to be inevitable in the long run. Despite intact protein synthesis and absence of cirrhotic complications, liver transplantation in the pre-cirrhotic stage for preventing malnutrition and to improve quality of life should be considered for these patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.49.2.276

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [12]12. Mahl MA, von Schonfeld J, Uppenkamp M, et al. Hemolytic anemia as cause of a marked bilirubin increase in primary biliary cirrhosis. Dtsch Med Wochenschr 1996;121:1226-8.

Cited by

Sorted by citations

Authors
Vleggaar, F. P., van Buuren, H. R., Zondervan, P. E., ten Kate, F. J. W., Hop, W. C. J., & the Dutch Multicentre PBC study group
Affiliations
  • Erasmus MC (NL)
  • aDepartment of Gastroenterology and Hepatology, University Hospital Rotterdam, the Netherlands, bDepartment of Pathology, University Hospital Rotterdam, the Netherlands, cDepartment of Pathology, Academic Medical Centre, Amsterdam, the Netherlands, dDepartment of Epidemiology and Biostatistics, Erasmus University Rotterdam, the Netherlands
Venue
Gut
Publisher
BMJ
Published
2001-08-01
Volume
49
Issue
2
Pages
276-281
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2142917855
Cited by
87
References
28
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 8 · 2018: 9 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 2
FWCI
1.99
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • UvA-DARE (University of Amsterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
primary biliary cirrhosis, cholestatic jaundice, bile duct loss, liver transplantation, pruritus, ursodeoxycholic acid, interlobular bile ducts, hyperbilirubinemia, disease progression
MeSH terms
Adult, Aged, Biopsy, Cholestasis, Intrahepatic, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Pruritus, Weight Loss, Case-Control Studies, Liver Transplantation, Endoscopy, Gastrointestinal, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review